Tradestie Institutional Equity Comparison Engine

PCLO vs GENM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PCLO Overall Edge

PCLO Captures Institutional Edge (1โ€“0 Pillars ยท 2โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to PCLO (PCLO) driven by superior Momentum & Technical. Fundamentally, PCLO trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus GENM at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, PCLO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GENM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
PCLO N/M vs GENM N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner PCLO
1Y +0.1% vs -1.6% ยท 52W Pos 17% vs 29%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
PCLO US Equity
PCLO
Institutional Equity
$25.00
+0.06% 1D
Market Cap N/A
1M Return +0.14%
1Y Return +0.12%
Forward P/E N/M
Unified AI Score
48.7 / 100 HOLD
Tech 39.0 Fund 53.0 Flow 50.0 Mom 50.0
GENM NYSE Arca
Genter Capital Municipal Quality Intermediate ETF
Institutional Equity
$10.16
+0.3% 1D
Market Cap N/A
1M Return +1.91%
1Y Return -1.55%
Forward P/E N/M
Unified AI Score
43.6 / 100 HOLD
Tech 35.0 Fund 47.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PCLO +0.12% GENM -1.55% Spread: +1.59 pp (PCLO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
PCLO TTM Op. Margin: N/A GENM TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PCLO vs GENM. Trailing 12-month operating profitability (PCLO N/A vs GENM N/A) and valuation multiples (PCLO N/M vs GENM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PCLO (2) vs GENM (1)
Institutional Metric PCLO GENM Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 17% ($25โ€“$26) 29% ($10โ€“$11) Stronger Trend GENM
Beta / 30D Volatility Risk Regime 0.00ฮฒ ยท 2% Vol 0.05ฮฒ ยท 3% Vol Lower Realized Risk PCLO
Unified Institutional Score Composite Signal 48.7 / 100 (HOLD) 43.6 / 100 (HOLD) Higher Composite PCLO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PCLO vs GENM Buy Guide
PCLO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PCLO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
GENM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GENM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PCLO nor GENM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.